178 related articles for article (PubMed ID: 38466660)
21. Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract.
Kleppa E; Ramsuran V; Zulu S; Karlsen GH; Bere A; Passmore JA; Ndhlovu P; Lillebø K; Holmen SD; Onsrud M; Gundersen SG; Taylor M; Kjetland EF; Ndung'u T
PLoS One; 2014; 9(6):e98593. PubMed ID: 24896815
[TBL] [Abstract][Full Text] [Related]
22. Detection of Schistosoma DNA in genital specimens and urine: A comparison between five female African study populations originating from S. haematobium and/or S. mansoni endemic areas.
Pillay P; Downs JA; Changalucha JM; Brienen EAT; Ramarokoto CE; Leutscher PDC; Vennervald BJ; Taylor M; Kjetland EF; Van Lieshout L
Acta Trop; 2020 Apr; 204():105363. PubMed ID: 32035055
[TBL] [Abstract][Full Text] [Related]
23. Female genital schistosomiasis (FGS): relationship between gynecological and histopathological findings.
Helling-Giese G; Sjaastad A; Poggensee G; Kjetland EF; Richter J; Chitsulo L; Kumwenda N; Racz P; Roald B; Gundersen SG; Krantz I; Feldmeier H
Acta Trop; 1996 Dec; 62(4):257-67. PubMed ID: 9028410
[TBL] [Abstract][Full Text] [Related]
24. A major hurdle in the elimination of urogenital schistosomiasis revealed: Identifying key gaps in knowledge and understanding of female genital schistosomiasis within communities and local health workers.
Kukula VA; MacPherson EE; Tsey IH; Stothard JR; Theobald S; Gyapong M
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007207. PubMed ID: 30897093
[TBL] [Abstract][Full Text] [Related]
25. Diagnosing Urogenital Schistosomiasis: Dealing with Diminishing Returns.
Le L; Hsieh MH
Trends Parasitol; 2017 May; 33(5):378-387. PubMed ID: 28094201
[TBL] [Abstract][Full Text] [Related]
26. Mapping Schistosoma haematobium for Novel Interventions against Female Genital Schistosomiasis and Associated HIV Risk in KwaZulu-Natal, South Africa.
Livingston M; Pillay P; Zulu SG; Sandvik L; Kvalsvig JD; Gagai S; Galappaththi-Arachchige HN; Kleppa E; Ndhlovu P; Vennervald B; Gundersen SG; Taylor M; Kjetland EF
Am J Trop Med Hyg; 2021 May; 104(6):2055-2064. PubMed ID: 33939629
[TBL] [Abstract][Full Text] [Related]
27. Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in northern Tanzania.
Poggensee G; Kiwelu I; Weger V; Göppner D; Diedrich T; Krantz I; Feldmeier H
J Infect Dis; 2000 Mar; 181(3):1210-3. PubMed ID: 10720558
[TBL] [Abstract][Full Text] [Related]
28. Knowledge of female genital schistosomiasis and urinary schistosomiasis among final-year midwifery students in the Volta Region of Ghana.
Azanu WK; Osarfo J; Appiah G; Godonu YS; Ampofo GD; Orish V; Amoh M; Agbeno EK; Morhe ESK; Gyapong M
PLoS One; 2024; 19(5):e0302554. PubMed ID: 38696499
[TBL] [Abstract][Full Text] [Related]
29. Integration of female genital schistosomiasis into HIV/sexual and reproductive health and rights and neglected tropical diseases programmes and services: a scoping review.
Umbelino-Walker I; Wong F; Cassolato M; Pantelias A; Jacobson J; Kalume C
Sex Reprod Health Matters; 2023 Dec; 31(1):2262882. PubMed ID: 37850814
[TBL] [Abstract][Full Text] [Related]
30. Female genital schistosomiasis (FGS): from case reports to a call for concerted action against this neglected gynaecological disease.
Christinet V; Lazdins-Helds JK; Stothard JR; Reinhard-Rupp J
Int J Parasitol; 2016 Jun; 46(7):395-404. PubMed ID: 27063073
[TBL] [Abstract][Full Text] [Related]
31. A quality improvement approach in co-developing a primary healthcare package for raising awareness and managing female genital schistosomiasis in Nigeria and Liberia.
Oluwole AS; Bettee AK; Nganda MM; Piotrowski HL; Fapohunda VO; Adejobi JB; Soneye IY; Kafil-Emiola MA; Soyinka FO; Nebe OJ; Ekpo UF; Kollie KK; Isiyaku S; Thomson R; Dean L; Ozano K;
Int Health; 2023 Mar; 15(Suppl 1):i30-i42. PubMed ID: 36960805
[TBL] [Abstract][Full Text] [Related]
32. Reversibility of lower reproductive tract abnormalities in women with Schistosoma haematobium infection after treatment with praziquantel--an interim report.
Richter J; Poggensee G; Kjetland EF; Helling-Giese G; Chitsulo L; Kumwenda N; Gundersen SG; Deelder AM; Reimert CM; Haas H; Krantz I; Feldmeier H
Acta Trop; 1996 Dec; 62(4):289-301. PubMed ID: 9028413
[TBL] [Abstract][Full Text] [Related]
33. Female genital schistosomiasis burden and risk factors in two endemic areas in Malawi nested in the Morbidity Operational Research for Bilharziasis Implementation Decisions (MORBID) cross-sectional study.
Lamberti O; Kayuni S; Kumwenda D; Ngwira B; Singh V; Moktali V; Dhanani N; Wessels E; Van Lieshout L; Fleming FM; Mzilahowa T; Bustinduy AL
PLoS Negl Trop Dis; 2024 May; 18(5):e0012102. PubMed ID: 38718065
[TBL] [Abstract][Full Text] [Related]
34. Detectable urogenital schistosome DNA and cervical abnormalities 6 months after single-dose praziquantel in women with Schistosoma haematobium infection.
Downs JA; Kabangila R; Verweij JJ; Jaka H; Peck RN; Kalluvya SE; Changalucha JM; Johnson WD; van Lieshout L; Fitzgerald DW
Trop Med Int Health; 2013 Sep; 18(9):1090-1096. PubMed ID: 23937701
[TBL] [Abstract][Full Text] [Related]
35. The social context of reproductive health in an Egyptian hamlet: a pilot study to identify female genital schistosomiasis.
Talaat M; Watts S; Mekheimar S; Farook Ali H; Hamed H
Soc Sci Med; 2004 Feb; 58(3):515-24. PubMed ID: 14652048
[TBL] [Abstract][Full Text] [Related]
36. The colposcopic atlas of schistosomiasis in the lower female genital tract based on studies in Malawi, Zimbabwe, Madagascar and South Africa.
Norseth HM; Ndhlovu PD; Kleppa E; Randrianasolo BS; Jourdan PM; Roald B; Holmen SD; Gundersen SG; Bagratee J; Onsrud M; Kjetland EF
PLoS Negl Trop Dis; 2014; 8(11):e3229. PubMed ID: 25412334
[TBL] [Abstract][Full Text] [Related]
37. Urine reagent strips for diagnosis of schistosomiasis haematobium in women of fertile age.
Gundersen SG; Kjetland EF; Poggensee G; Helling-Giese G; Richter J; Chitsulo L; Koumwenda N; Krantz I; Feldmeier H
Acta Trop; 1996 Dec; 62(4):281-7. PubMed ID: 9028412
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities.
Ndeffo Mbah ML; Gilbert JA; Galvani AP
Epidemics; 2014 Jun; 7():22-7. PubMed ID: 24928666
[TBL] [Abstract][Full Text] [Related]
39. Novel tools and strategies for breaking schistosomiasis transmission: study protocol for an intervention study.
Trippler L; Hattendorf J; Ali SM; Ame SM; Juma S; Kabole F; Knopp S
BMC Infect Dis; 2021 Sep; 21(1):1024. PubMed ID: 34592960
[TBL] [Abstract][Full Text] [Related]
40. Female genital schistosomiasis as a risk-factor for the transmission of HIV.
Feldmeier H; Krantz I; Poggensee G
Int J STD AIDS; 1994; 5(5):368-72. PubMed ID: 7819359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
